Wockhardt has received USFDA nod for analgesic drug Oxycodone hydrochloride.
Wockhardt is trading on a robust note in early morning deals on the BSE, on the back of positive news flow.
According to media reports, Wockhardt has received United States Food & Drug Administration (USFDA) nod for analgesic drug Oxycodone hydrochloride.
Following which, the scrip rallied to a high of Rs. 1,450. Now, Wockhardt is up over 3.5 percent at Rs. 1,446.
The counter has seen trades of around 64,000 shares as against the two-week daily average volume of 255,000 shares.
Meanwhile, the BSE Sensex has gained 153 points at 27,470.
According to media reports, Wockhardt has received United States Food & Drug Administration (USFDA) nod for analgesic drug Oxycodone hydrochloride.
Following which, the scrip rallied to a high of Rs. 1,450. Now, Wockhardt is up over 3.5 percent at Rs. 1,446.
The counter has seen trades of around 64,000 shares as against the two-week daily average volume of 255,000 shares.
Meanwhile, the BSE Sensex has gained 153 points at 27,470.
No comments:
Post a Comment